Australia Approves Faecal Transplants For Intestinal Health
Australia is the first country in the world to have awarded regulatory approval for faeces transplants.
The healthy genetic material for this donation comes from...
ProductLife, EIT Health Team-Up For Legal & Compliance
ProductLife Group (PLG), a supplier of regulation and compliance solutions for the life sciences sector, has joined the Venture Centre of Excellence, EIT Health's...
NHS Acquires Potentially Lifesaving Breast Cancer Medication
The confidential agreement reached by the NHS and the manufacturer is expected to assist up to 1,600 women annually who have high-risk, triple-negative breast...
Transfusion of The First Patients Lab-Grown Blood Cells
In the first clinical trial of its sort, lab-grown blood cells were administered to a second patient, potentially paving the way for future therapies...
Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH
The 64th annual meeting of the American Society of Hematology, a prestigious venue for some of their field's most significant research, will be held...
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
The effectiveness of aducanumab and donanemab in treating Alzheimer's disease (AD) was successfully simulated using a novel computer model, demonstrating how a steady rise...
$2 Million Gene Therapy Might Become The Standard In The US
In recent years, the high cost of gene therapies has emerged as a major barrier to the development of personalised medicines. Most notably, bluebird...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...